| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 21:03:48 UTC |
|---|
| Update Date | 2021-09-14 15:45:34 UTC |
|---|
| HMDB ID | HMDB0029128 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Valylhydroxyproline |
|---|
| Description | Valylhydroxyproline, also known as V-HP dipeptide or val-hpro, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Valylhydroxyproline has been detected, but not quantified in, a few different foods, such as anatidaes (Anatidae), chickens (Gallus gallus), and domestic pigs (Sus scrofa domestica). This could make valylhydroxyproline a potential biomarker for the consumption of these foods. Based on a literature review very few articles have been published on Valylhydroxyproline. |
|---|
| Structure | CC(C)[C@H](N)C(=O)N1C[C@H](O)C[C@H]1C(O)=O InChI=1S/C10H18N2O4/c1-5(2)8(11)9(14)12-4-6(13)3-7(12)10(15)16/h5-8,13H,3-4,11H2,1-2H3,(H,15,16)/t6-,7+,8+/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| Valine hydroxyproline dipeptide | HMDB | | L-Valyl-L-hydroxyproline | HMDB | | V-HP Dipeptide | HMDB | | Val-hpro | HMDB | | Valine-hydroxyproline dipeptide | HMDB | | VHP Dipeptide | HMDB | | Val-hyp | HMDB | | L-Val-L-hyp | HMDB | | Valyl-hydroxyproline | HMDB | | (2S,4R)-1-[(2S)-2-Amino-3-methylbutanoyl]-4-hydroxypyrrolidine-2-carboxylate | HMDB | | Valylhydroxyproline | HMDB |
|
|---|
| Chemical Formula | C10H18N2O4 |
|---|
| Average Molecular Weight | 230.264 |
|---|
| Monoisotopic Molecular Weight | 230.126657068 |
|---|
| IUPAC Name | (2S,4R)-1-[(2S)-2-amino-3-methylbutanoyl]-4-hydroxypyrrolidine-2-carboxylic acid |
|---|
| Traditional Name | (2S,4R)-1-[(2S)-2-amino-3-methylbutanoyl]-4-hydroxypyrrolidine-2-carboxylic acid |
|---|
| CAS Registry Number | 90965-79-0 |
|---|
| SMILES | CC(C)[C@H](N)C(=O)N1C[C@H](O)C[C@H]1C(O)=O |
|---|
| InChI Identifier | InChI=1S/C10H18N2O4/c1-5(2)8(11)9(14)12-4-6(13)3-7(12)10(15)16/h5-8,13H,3-4,11H2,1-2H3,(H,15,16)/t6-,7+,8+/m1/s1 |
|---|
| InChI Key | IMOKOCYUKGZZAG-CSMHCCOUSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Dipeptides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Alpha-dipeptide
- Valine or derivatives
- Proline or derivatives
- N-acyl-alpha-amino acid
- N-acyl-l-alpha-amino acid
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid amide
- Alpha-amino acid or derivatives
- Pyrrolidine carboxylic acid
- Pyrrolidine carboxylic acid or derivatives
- N-acylpyrrolidine
- Pyrrolidine
- Tertiary carboxylic acid amide
- Secondary alcohol
- Amino acid or derivatives
- Carboxamide group
- Amino acid
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Azacycle
- Organoheterocyclic compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Primary aliphatic amine
- Alcohol
- Organic oxide
- Carbonyl group
- Organopnictogen compound
- Amine
- Organic oxygen compound
- Organonitrogen compound
- Organooxygen compound
- Primary amine
- Aliphatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aliphatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | -3.37 | Extrapolated |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.48 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.657 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 8.3 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 377.5 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 547.7 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 231.1 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 59.0 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 157.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 44.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 286.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 254.0 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 719.4 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 585.4 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 59.0 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 775.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 166.4 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 184.9 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 512.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 507.3 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 313.5 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Valylhydroxyproline,1TMS,isomer #1 | CC(C)[C@H](N)C(=O)N1C[C@H](O[Si](C)(C)C)C[C@H]1C(=O)O | 2007.3 | Semi standard non polar | 33892256 | | Valylhydroxyproline,1TMS,isomer #2 | CC(C)[C@H](N)C(=O)N1C[C@H](O)C[C@H]1C(=O)O[Si](C)(C)C | 1932.5 | Semi standard non polar | 33892256 | | Valylhydroxyproline,1TMS,isomer #3 | CC(C)[C@H](N[Si](C)(C)C)C(=O)N1C[C@H](O)C[C@H]1C(=O)O | 1994.6 | Semi standard non polar | 33892256 | | Valylhydroxyproline,2TMS,isomer #1 | CC(C)[C@H](N)C(=O)N1C[C@H](O[Si](C)(C)C)C[C@H]1C(=O)O[Si](C)(C)C | 1976.2 | Semi standard non polar | 33892256 | | Valylhydroxyproline,2TMS,isomer #2 | CC(C)[C@H](N[Si](C)(C)C)C(=O)N1C[C@H](O[Si](C)(C)C)C[C@H]1C(=O)O | 2015.8 | Semi standard non polar | 33892256 | | Valylhydroxyproline,2TMS,isomer #3 | CC(C)[C@H](N[Si](C)(C)C)C(=O)N1C[C@H](O)C[C@H]1C(=O)O[Si](C)(C)C | 1989.2 | Semi standard non polar | 33892256 | | Valylhydroxyproline,2TMS,isomer #4 | CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 2125.8 | Semi standard non polar | 33892256 | | Valylhydroxyproline,3TMS,isomer #1 | CC(C)[C@H](N[Si](C)(C)C)C(=O)N1C[C@H](O[Si](C)(C)C)C[C@H]1C(=O)O[Si](C)(C)C | 2001.3 | Semi standard non polar | 33892256 | | Valylhydroxyproline,3TMS,isomer #1 | CC(C)[C@H](N[Si](C)(C)C)C(=O)N1C[C@H](O[Si](C)(C)C)C[C@H]1C(=O)O[Si](C)(C)C | 2084.0 | Standard non polar | 33892256 | | Valylhydroxyproline,3TMS,isomer #2 | CC(C)[C@@H](C(=O)N1C[C@H](O[Si](C)(C)C)C[C@H]1C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 2180.2 | Semi standard non polar | 33892256 | | Valylhydroxyproline,3TMS,isomer #2 | CC(C)[C@@H](C(=O)N1C[C@H](O[Si](C)(C)C)C[C@H]1C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 2184.3 | Standard non polar | 33892256 | | Valylhydroxyproline,3TMS,isomer #3 | CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 2136.1 | Semi standard non polar | 33892256 | | Valylhydroxyproline,3TMS,isomer #3 | CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 2148.3 | Standard non polar | 33892256 | | Valylhydroxyproline,4TMS,isomer #1 | CC(C)[C@@H](C(=O)N1C[C@H](O[Si](C)(C)C)C[C@H]1C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 2212.9 | Semi standard non polar | 33892256 | | Valylhydroxyproline,4TMS,isomer #1 | CC(C)[C@@H](C(=O)N1C[C@H](O[Si](C)(C)C)C[C@H]1C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 2225.1 | Standard non polar | 33892256 | | Valylhydroxyproline,1TBDMS,isomer #1 | CC(C)[C@H](N)C(=O)N1C[C@H](O[Si](C)(C)C(C)(C)C)C[C@H]1C(=O)O | 2241.5 | Semi standard non polar | 33892256 | | Valylhydroxyproline,1TBDMS,isomer #2 | CC(C)[C@H](N)C(=O)N1C[C@H](O)C[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 2177.1 | Semi standard non polar | 33892256 | | Valylhydroxyproline,1TBDMS,isomer #3 | CC(C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N1C[C@H](O)C[C@H]1C(=O)O | 2220.1 | Semi standard non polar | 33892256 | | Valylhydroxyproline,2TBDMS,isomer #1 | CC(C)[C@H](N)C(=O)N1C[C@H](O[Si](C)(C)C(C)(C)C)C[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 2444.6 | Semi standard non polar | 33892256 | | Valylhydroxyproline,2TBDMS,isomer #2 | CC(C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N1C[C@H](O[Si](C)(C)C(C)(C)C)C[C@H]1C(=O)O | 2478.5 | Semi standard non polar | 33892256 | | Valylhydroxyproline,2TBDMS,isomer #3 | CC(C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N1C[C@H](O)C[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 2440.1 | Semi standard non polar | 33892256 | | Valylhydroxyproline,2TBDMS,isomer #4 | CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2564.0 | Semi standard non polar | 33892256 | | Valylhydroxyproline,3TBDMS,isomer #1 | CC(C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N1C[C@H](O[Si](C)(C)C(C)(C)C)C[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 2685.6 | Semi standard non polar | 33892256 | | Valylhydroxyproline,3TBDMS,isomer #1 | CC(C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N1C[C@H](O[Si](C)(C)C(C)(C)C)C[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 2646.9 | Standard non polar | 33892256 | | Valylhydroxyproline,3TBDMS,isomer #2 | CC(C)[C@@H](C(=O)N1C[C@H](O[Si](C)(C)C(C)(C)C)C[C@H]1C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2847.9 | Semi standard non polar | 33892256 | | Valylhydroxyproline,3TBDMS,isomer #2 | CC(C)[C@@H](C(=O)N1C[C@H](O[Si](C)(C)C(C)(C)C)C[C@H]1C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2773.9 | Standard non polar | 33892256 | | Valylhydroxyproline,3TBDMS,isomer #3 | CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2787.9 | Semi standard non polar | 33892256 | | Valylhydroxyproline,3TBDMS,isomer #3 | CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2745.1 | Standard non polar | 33892256 | | Valylhydroxyproline,4TBDMS,isomer #1 | CC(C)[C@@H](C(=O)N1C[C@H](O[Si](C)(C)C(C)(C)C)C[C@H]1C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3050.6 | Semi standard non polar | 33892256 | | Valylhydroxyproline,4TBDMS,isomer #1 | CC(C)[C@@H](C(=O)N1C[C@H](O[Si](C)(C)C(C)(C)C)C[C@H]1C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2931.9 | Standard non polar | 33892256 |
|
|---|